Brain implant aims to stifle drug highs

July 29, 2013

What happens if addicts get no high from the drugs they take? Researchers at Case Western Reserve and Illinois State universities have received a $390,000 National Institute on Drug Abuse grant to help answer the question.

Addiction experts believe a mechanism that robs drugs of their ability to hook users could treat and possibly cure drug abuse and even dependence.

Pedram Mohseni, an associate professor of electrical engineering and computer science at Case Western Reserve, is building—and will soon start testing—a aimed at sensing changes in the dopamine levels when a rat is given addictive substances and suppressing the reward-related signals associated with a pleasurable high.

"The idea is to build a closed-loop microsystem that senses and identifies changes in the dopamine levels induced by drugs of abuse, then activates a stimulator in real time to suppress the reward-related signals that promote drug-seeking behavior," said Mohseni, the leader of device development for the research project.

Mohseni has a first-generation prototype implant nearly ready and will take the device to Paul A. Garris, a professor of biological sciences at Illinois State, who will lead device testing in anesthetized as early as next month.

Mohseni's system is connected to a chemical that senses changes in the brain when a highly addictive amphetamine is administered.

The drug hyperactivates phasic dopamine signaling, or transient dopamine concentration spikes, which control pathways. This can lead to altered synaptic signaling and in turn overvaluation of cues predicting drug availability, leading to drug reinforcement, Mohseni said.

A computer circuit in the microsystem will use algorithms to determine if the drug-induced phasic dopamine signaling exceeds a threshold level set in the absence of drugs. When the threshold is exceeded, the system will then send to a stimulating electrode in the brain. The impulses are designed to inhibit dopamine neurons, silencing the phasic dopamine signaling.

Mohseni and Garris will spend the next two years evaluating and improving the microsystem. They plan to then seek another grant to test the device on rats that are awake and monitor changes in behavior.

Explore further: Feeding hormone ghrelin modulates ability of rewarding food to evoke dopamine release

Related Stories

Recommended for you

Alcoholics may lack key enzyme

September 22, 2016

(HealthDay)—Alcoholics may lack an enzyme that would help them control their impulse to drink, a new study with rats suggests.

People with alcohol dependency lack important enzyme

August 30, 2016

A research group under the leadership of Linköping University Professor Markus Heilig has identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops. The deficiency ...

Gamblers more prone to violent behavior

September 6, 2016

Men who gamble are more likely to act violently towards others, with the most addicted gamblers the most prone to serious violence, new research has shown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.